Calliditas Therapeutics
CALT
#5841
Rank
$0.59 B
Marketcap
$22.19
Share price
1.32%
Change (1 day)
12.81%
Change (1 year)

P/S ratio for Calliditas Therapeutics (CALT)

P/S ratio as of May 2024 (TTM): 4.38

According to Calliditas Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.38406. At the end of 2023 the company had a P/S ratio of 4.40.

P/S ratio history for Calliditas Therapeutics from 2020 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20234.40-25.89%
20225.93-76.2%
202124.9-99.71%
2020> 1000